Co-Diagnostics CODX

Co-Diagnostics, Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus

$0.13-21.52%close on Nov. 20, 2026 · volume 1.1M · Yahoo Finance

Price, last 64 sessions

$0.50$1.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 20, 2026 · high $1.26 · low $0.13 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 22 →
  • 8-KNov. 20, 2026, 4:30 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits

  • 8-KNov. 19, 2026, 5:10 p.m. ETView on SEC.govOur explainer

    Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCo-Diagnostics announces 1-for-25 reverse stock split effective November 24, 2026, to support Nasdaq $1.00 minimum bid compliance

  • 8-KNov. 13, 2026, 5 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Submission of matters to a vote of security holders · Financial statements and exhibits

    AI summary, unreviewedCo-Diagnostics Shareholders Approve Plan Share Increase, Reverse Split Authority of Up to 1-for-750 and Warrant Issuance at Special Meeting

  • 10-QNov. 10, 2026, 4:05 p.m. ETView on SEC.gov
  • 8-KNov. 10, 2026, 8:02 a.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCo-Diagnostics Q3 2026 Net Loss Narrows to $1.01 Per Share vs $1.25 Consensus; Revenue Rises to $0.3 Million, Cash Falls to $0.7 Million

  • 8-KOct. 15, 2026, 4:15 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

  • 8-K/AOct. 15, 2026, 6:10 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits

  • 8-KOct. 13, 2026, 6:10 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits